| 名称 | 成立时间 | | 轮次 | 金额 | | | --- | --- | --- | --- | --- | --- | | 柏垠生物 | 2021年 | 合成生物企业 | 战略融资 | 未披露 | 包括富华资本、广药资本及 | | | | | | | 鲸犀投资 | | 恩泽康泰 | 2017年 | 外泌体科技企业 | B轮 | 近亿元 | 中博聚力领投 | | 臻奏生物 | 2023年 | 医美材料研发商 | Pre-A轮 | 未披露 | 昆山高新集团 | | Xinú | 2017年 | 墨西哥高端香水品 牌 | 股权投资 | 未披露 | 雅诗兰黛宣布通过旗下战略 早期投资部门New Incubation Ventures | | | | | | | A (NIV) | | 修实生物 | 2020年 | 深耕多肽生物合成 领域 | A轮 | 近亿元 | 创景资本领投 | | 巨微生物 | 2024年 | 合成生物技术研发 | A+轮 | | | | | | 問 | | 未披露 | 包括金科君创 | | LAN 兰 | 2019年 | 中国纯净护肤品牌 | 少数股权投资 | 未披露 | 欧莱雅中国 ...

Core Viewpoint - The company has established an advanced technology platform and product library in the field of non-natural amino acids, with a commitment to continuous technological innovation to support global customers in drug development [1] Summary by Categories Technology and Product Development - The company has developed tens of thousands of non-natural amino acids, with over 10,000 catalog products available [1] - More than 1,300 products are in stock, and over 100 products have kilogram-level production experience [1] - The company can supply over 20 products at the hundred-kilogram level [1] Commitment to Innovation - The company is dedicated to providing high-quality non-natural amino acid products and related technical services to assist in innovative drug research and development [1]